Results

Total Results: 14 records

Showing results for "weight".
Users also searched for: obesity screening

  1. srdrplus.ahrq.gov/published_projects?page=48
    October 31, 2022 - We examined four major outcomes: binge eating and abstinence, eating-related psychopathology, weight, … Topiramate and lisdexamfetamine produced weight reduction in study populations that were virtually all … CBT for BED was generally ineffective for reducing weight or depression in this population. … Behavioral weight loss treatment produced greater weight loss than CBT at the end of treatment but not … Treatments for LOC eating in children did not achieve superior weight reduction outcomes.
  2. srdrplus.ahrq.gov/published_projects?page=32
    June 27, 2021 - testing modalities and assessed the comparative effectiveness of exercise training, medical therapy, weight … trials, 6 observational) evaluated the comparative effectiveness of exercise training, medical therapy, weight … trials, 5 observational) evaluated the comparative effectiveness of exercise training, medical therapy, weight
  3. srdrplus.ahrq.gov/published_projects?page=53
    March 03, 2021 - For eating disorder patients specifically, evidence shows that atypicals are do not cause significant weight … In nonelderly adults, adverse events included weight gain (particularly with olanzapine), fatigue, sedation
  4. srdrplus.ahrq.gov/published_projects?page=47
    June 23, 2021 - READ MORE Published on June 23, 2021 Low-calorie sweeteners and body weight and composition: a meta-analysis … cohort studies, separately, that examined the relationship between low-calorie sweeteners and body weight
  5. srdrplus.ahrq.gov/published_projects?page=49
    June 23, 2021 - Compared with metformin, thiazolidinediones and sulfonylureas had a more unfavorable effect on weight … Low molecular weight heparins (LMWHs) reduced PE (OR 0.48 [0.24 to 0.95], SOE: M, AOE: L), DVT (RR 0.80
  6. srdrplus.ahrq.gov/published_projects?page=54
    March 03, 2021 - substantially in those treated with insulin versus insulin analogues or oral agents; (2) average infant birth weight
  7. srdrplus.ahrq.gov/published_projects?page=52
    March 07, 2023 - for prolactin-related events; and both quetiapine and risperidone were favored over olanzapine for weight
  8. srdrplus.ahrq.gov/published_projects?page=30
    June 27, 2021 - extrapyramidal symptoms compared to placebo, and those using olanzapine reported more clinically significant weight … extrapyramidal symptoms compared with placebo, and those using olanzapine reported more clinically significant weight
  9. srdrplus.ahrq.gov/published_projects?page=55
    March 01, 2021 - CI 0.20, 8.43, P=0.04) when a free fructose enriched excess energy diet was compared to a habitual weight
  10. srdrplus.ahrq.gov/published_projects?page=51
    June 23, 2021 - of nausea and vomiting, sertraline to higher rates of diarrhea, and mirtazapine to higher rates of weight
  11. srdrplus.ahrq.gov/published_projects?page=45
    June 23, 2021 - body of literature evidence exists on low-calorie sweeteners yet the health effects of LCS beyond body weight
  12. srdrplus.ahrq.gov/published_projects?page=24
    October 31, 2022 - dysfunction compared to DPP-4Is; DPP-4Is(sitagliptin)may exert a less potent effect on HbA1C, FPG, PPG, and weight
  13. srdrplus.ahrq.gov/published_projects?page=25
    June 27, 2021 - ART regimens associated with increased risk of preterm delivery without increased risk of low birth weight
  14. srdrplus.ahrq.gov/published_projects?page=8
    May 30, 2023 - Most studies evaluated changes in weight/body composition, adverse events, length of hospital stay and

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: